74
Views
5
CrossRef citations to date
0
Altmetric
Original Research

MALAT-1 is Associated with the Doxorubicin Resistance in U-2OS Osteosarcoma Cells

, , , , , & show all
Pages 6879-6889 | Published online: 01 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chang Shi, Shuangjie Ren, Xiaodong Zhao & Qinghuai Li. (2022) lncRNA MALAT1 Regulates the Resistance of Breast Cancer Cells to Paclitaxel Via the miR-497-5p/ SHOC2 axis. Pharmacogenomics 23:18, pages 973-985.
Read now

Articles from other publishers (4)

Natascha Leitner, Reinhard Ertl, Simone Gabner, Andrea Fuchs-Baumgartinger, Ingrid Walter & Juraj Hlavaty. (2023) Isolation and Characterization of Novel Canine Osteosarcoma Cell Lines from Chemotherapy-Naïve Patients. Cells 12:7, pages 1026.
Crossref
Lijuan Fan, Zhenhao Zhong, Yubo Lin & Jitian Li. (2022) Non-coding RNAs as potential biomarkers in osteosarcoma. Frontiers in Genetics 13.
Crossref
Maryam Farzaneh, Sajad Najafi, Omid Anbiyaee, Shirin Azizidoost & Seyed Esmaeil Khoshnam. (2022) LncRNA MALAT1-related signaling pathways in osteosarcoma. Clinical and Translational Oncology 25:1, pages 21-32.
Crossref
Junchao Huang, Jingwei Zhang & Haijun Xiao. (2022) Identification of Epigenetic-Dysregulated lncRNAs Signature in Osteosarcoma by Multi-Omics Data Analysis. Frontiers in Medicine 9.
Crossref